查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1124825

急性胆囊炎的全球市场 (～2027年):各类型、原因、诊断 (超音波检验、胆管闪烁图术、电脑断层扫描、ERCP、其他)、治疗、终端用户、地区的竞争预测、机会

Global Acute Cholecystitis Market, By Type By Cause By Diagnostic Procedure (Ultrasonography, Cholescintigraphy, CT Scan, ERCP, Others) By Treatment By End User By Region, Competition Forecast and Opportunities, 2027
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球急性胆囊炎的市场预计从2023年到2027年以高年复合成长率成长。

该市场的成长，起因于胆囊结石的发生数增加。还有製药企业开发平台药物中R&D的进步，及老年人口增加，健康状态的恶化倾向等也预计更加促进今后的市场成长。

本报告提供全球急性胆囊炎的市场调查，市场概要，市场规模的变化、预测，各种区分、各地区/主要国家的明细，市场的各种影响因素的分析，竞争环境，市场占有率，主要企业简介等彙整资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 COVID-19:对全球急性胆囊炎市场的影响

第4章 摘要整理

第5章 VOC (客户的迴响)

第6章 全球急性胆囊炎市场预测

  • 市场规模、预测
  • 市场占有率、预测
    • 各类型(结石性急性胆囊炎、无石头性急性胆囊炎)
    • 各原因(胆囊结石、肿瘤、胆管闭塞、微生物感染、其他)
    • 各诊断(超音波检验、胆管闪烁图术、电脑断层扫描、ERCP、其他)
    • 各治疗(外科的、非外科的)
    • 各终端用户(医院及诊疗所、门诊病人手术中心、其他)
    • 各企业
    • 各地区
  • 产品市场地图

第7章 北美的急性胆囊炎市场预测

  • 市场规模、预测
  • 市场占有率、预测
    • 各类型
    • 各原因
    • 各诊断
    • 各治疗
    • 各终端用户
    • 各国
  • 各国分析

第8章 欧洲的急性胆囊炎市场预测

  • 市场规模、预测
  • 市场占有率、预测
    • 各类型
    • 各原因
    • 各诊断
    • 各治疗
    • 各终端用户
    • 各国
  • 各国分析

第9章 亚太地区的急性胆囊炎市场预测

  • 市场规模、预测
  • 市场占有率、预测
    • 各类型
    • 各原因
    • 各诊断
    • 各治疗
    • 各终端用户
    • 各国
  • 各国分析

第10章 南美的急性胆囊炎市场预测

  • 市场规模、预测
  • 市场占有率、预测
    • 各类型
    • 各原因
    • 各诊断
    • 各治疗
    • 各终端用户
    • 各国
  • 各国分析

第11章 中东及非洲的急性胆囊炎市场预测

  • 市场规模、预测
  • 市场占有率、预测
    • 各类型
    • 各原因
    • 各诊断
    • 各治疗
    • 各终端用户
    • 各国
  • 各国分析

第12章 市场动态

  • 促进因素
  • 课题

第13章 市场趋势、市场展开

第14章 竞争情形

  • 竞争预测
  • 企业简介(主要5家公司的SWOT分析)
    • Boston Scientific Corporation
    • Fresenius Kabi AG
    • Pfizer Inc
    • Teva Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals Limited
    • Merck & Co., Inc.
    • Becton, Dickinson and Company
    • Simulab Corporation
    • AbbVie, Inc.
    • Fortimedix Surgical BV

第15章 策略性建议

简介目录
Product Code: 9316

Global acute cholecystitis market is projected to accomplish an extraordinary growth in the forecast period, 2023-2027 with an impressive CAGR. The market growth can be attributed to the rising instances of gall bladder stone issues. The population is now more concerned and aware of the condition and demanding efficient and effective treatment for the same thereby aiding to the growth of the global acute cholecystitis market in the upcoming five years. Moreover, rapidly increasing research and advancement in the pharmaceutical department that has effective drugs in the pipeline of market launch is further enunciating the growth factors of the global acute cholecystitis market in the next five years. Increasing geriatric population and their tendency of weaker health and poor health conditions are further aiding the growth of the market in the near future.

Health insurances, governmental schemes have made it more feasible for the patients to afford the treatments ad thus supporting the growth of the market. The market may experience a mild restraint due to health conscious consumers that have now changed food habits and are rejuvenating their bodies with healthier food.

Market Segmentation

The global acute cholecystitis market is segmented by type, cause, diagnostic procedure, treatment, end user, regional distribution, and competitional landscape. Based on type, the market is differentiated between calculous acute cholecystitis and acalculous acute cholecystitis. By cause, the market is further segmented into gall bladder stones, tumor, bile duct blockage, microbial infection, and others. Based on diagnostic procedure, the market is fragmented into ultrasonography, cholescintigraphy, CT scan, ERCP (endoscopic retrograde cholangiopancreatography), and others. By treatment the market is differentiated between surgical and non-surgical. Based on end user, the market is bifurcated into hospitals & clinics, ambulatory surgical centers, and others. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Based on type, Acute Cholecystitis May Lead Market Growth

Based on type, the market is further divided between calculous acute cholecystitis and acalculous acute cholecystitis. Depending on the obstruction site the acute cholecystitis is of two types. Acute cholecystitis is a medical condition where stone-like obstructions are accumulated in the gallbladder, or the gastro-intestinal tube that connects gallbladder to the small intestine. If the obstruction is at the gall bladder duct it is termed as calculous acute cholecystitis and if the obstruction is at any other site in the gall bladder or the tube, it is termed as acalculous acute cholecystitis. Calculous acute cholecystitis is a worse condition of gall bladder condition and requires immediate attention thereby is anticipated to hold the larger market revenue shares and assert its dominance over the market segment. Acalculous acute cholecystitis is also an emergency situation but is comparatively less painful and may register significant growth in the market shares in the next five years.

Company Profile

Holding the major shares of the global acute cholecystitis market are Boston Scientific Corporation, Fresenius Kabi AG, Pfizer Inc, Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Limited, Merck & Co., Inc., Becton, Dickinson and Company, Simulab Corporation, AbbVie, Inc., Fortimedix Surgical BV, among others. Market players are actively involved in the research and technological development in the medical device and testing kit developments diagnosing the condition at an earlier stage. The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services for acute cholecystitis. Further advancement would aid the market value and brand establishment in the future five years.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2023-2027

Objective of the Study:

  • To analyze the historical growth of the market size of global acute cholecystitis market from 2017 to 2020.
  • To estimate and forecast the market size of global acute cholecystitis market from 2021 to 2027 and growth rate until 2027.
  • To classify and forecast global acute cholecystitis market based on type, cause, diagnostic procedure, treatment, end user, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global acute cholecystitis market.
  • To identify drivers and challenges for global acute cholecystitis market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global acute cholecystitis market.
  • To identify and analyze the profile of leading players operating in global acute cholecystitis market.
  • To identify key sustainable strategies adopted by market players in global acute cholecystitis market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals, surgical centers, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global acute cholecystitis market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Hospitals, medical practitioners, end users, and other stakeholders
  • Distributers and suppliers of products and other stakeholders
  • Organizations, forums, and alliances related to acute cholecystitis
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global Acute Cholecystitis market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Acute Cholecystitis Market, By Type:

Calculous Acute Cholecystitis

Acalculous Acute Cholecystitis

  • Global Acute Cholecystitis Market, By Cause:

Gall Bladder Stones

Tumor

Bile Duct Blockage

Microbial Infection

Others

  • Global Acute Cholecystitis Market, By Diagnostic Procedure:

Ultrasonography

Cholescintigraphy

CT Scan

ERCP (Endoscopic Retrograde Cholangiopancreatography)

Others

  • Global Acute Cholecystitis Market, By Treatment:

Surgical

Non-Surgical

  • Global Acute Cholecystitis Market, By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Others

  • Global Acute Cholecystitis Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Sweden

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Bangladesh

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey

South America

  • Brazil
  • Argentina
  • Colombia
  • Chile

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global acute cholecystitis market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Acute Cholecystitis Treatment Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Factors Contributing to Prevalence of Acute Cholecystitis
  • 5.2. Prevalence of Acute Cholecystitis, By Gender
  • 5.3. Prevalence of Acute Cholecystitis, By Age Group
  • 5.4. Preferred choice of Treatment for Acute Cholecystitis

6. Global Acute Cholecystitis Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Calculous Acute Cholecystitis v/s Acalculous Acute Cholecystitis)
    • 6.2.2. By Cause (Gall Bladder Stones, Tumor, Bile Duct Blockage, Microbial Infection, Others)
    • 6.2.3. By Diagnostic Procedure (Ultrasonography, Cholescintigraphy, CT Scan, ERCP (Endoscopic Retrograde Cholangiopancreatography), Others)
    • 6.2.4. By Treatment (Surgical v/s Non-Surgical)
    • 6.2.5. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 6.2.6. By Company (2021)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. North America Acute Cholecystitis Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Cause
    • 7.2.3. By Diagnostic Procedure
    • 7.2.4. By Treatment
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Acute Cholecystitis Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Cause
        • 7.3.1.2.3. By Diagnostic Procedure
        • 7.3.1.2.4. By Treatment
        • 7.3.1.2.5. By End User
    • 7.3.2. Mexico Acute Cholecystitis Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Cause
        • 7.3.2.2.3. By Diagnostic Procedure
        • 7.3.2.2.4. By Treatment
        • 7.3.2.2.5. By End User
    • 7.3.3. Canada Acute Cholecystitis Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Cause
        • 7.3.3.2.3. By Diagnostic Procedure
        • 7.3.3.2.4. By Treatment
        • 7.3.3.2.5. By End User

8. Europe Acute Cholecystitis Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Cause
    • 8.2.3. By Diagnostic Procedure
    • 8.2.4. By Treatment
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Acute Cholecystitis Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Cause
        • 8.3.1.2.3. By Diagnostic Procedure
        • 8.3.1.2.4. By Treatment
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Acute Cholecystitis Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Cause
        • 8.3.2.2.3. By Diagnostic Procedure
        • 8.3.2.2.4. By Treatment
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Acute Cholecystitis Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Cause
        • 8.3.3.2.3. By Diagnostic Procedure
        • 8.3.3.2.4. By Treatment
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Acute Cholecystitis Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Cause
        • 8.3.4.2.3. By Diagnostic Procedure
        • 8.3.4.2.4. By Treatment
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Acute Cholecystitis Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Cause
        • 8.3.5.2.3. By Diagnostic Procedure
        • 8.3.5.2.4. By Treatment
        • 8.3.5.2.5. By End User
    • 8.3.6. Sweden Acute Cholecystitis Treatment Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type
        • 8.3.6.2.2. By Cause
        • 8.3.6.2.3. By Diagnostic Procedure
        • 8.3.6.2.4. By Treatment
        • 8.3.6.2.5. By End User

9. Asia-Pacific Acute Cholecystitis Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Cause
    • 9.2.3. By Diagnostic Procedure
    • 9.2.4. By Treatment
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Acute Cholecystitis Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Cause
        • 9.3.1.2.3. By Diagnostic Procedure
        • 9.3.1.2.4. By Treatment
        • 9.3.1.2.5. By End User
    • 9.3.2. India Acute Cholecystitis Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Cause
        • 9.3.2.2.3. By Diagnostic Procedure
        • 9.3.2.2.4. By Treatment
        • 9.3.2.2.5. By End User
    • 9.3.3. South Korea Acute Cholecystitis Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Cause
        • 9.3.3.2.3. By Diagnostic Procedure
        • 9.3.3.2.4. By Treatment
        • 9.3.3.2.5. By End User
    • 9.3.4. Japan Acute Cholecystitis Treatment Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Cause
        • 9.3.4.2.3. By Diagnostic Procedure
        • 9.3.4.2.4. By Treatment
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Acute Cholecystitis Treatment Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Cause
        • 9.3.5.2.3. By Diagnostic Procedure
        • 9.3.5.2.4. By Treatment
        • 9.3.5.2.5. By End User
    • 9.3.6. Thailand Acute Cholecystitis Treatment Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Type
        • 9.3.6.2.2. By Cause
        • 9.3.6.2.3. By Diagnostic Procedure
        • 9.3.6.2.4. By Treatment
        • 9.3.6.2.5. By End User
    • 9.3.7. Bangladesh Cholecystitis Treatment Market Outlook
      • 9.3.7.1. Market Size & Forecast
        • 9.3.7.1.1. By Value
      • 9.3.7.2. Market Share & Forecast
        • 9.3.7.2.1. By Type
        • 9.3.7.2.2. By Cause
        • 9.3.7.2.3. By Diagnostic Procedure
        • 9.3.7.2.4. By Treatment
        • 9.3.7.2.5. By End User

10. South America Acute Cholecystitis Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Cause
    • 10.2.3. By Diagnostic Procedure
    • 10.2.4. By Treatment
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Acute Cholecystitis Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Cause
        • 10.3.1.2.3. By Diagnostic Procedure
        • 10.3.1.2.4. By Treatment
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Acute Cholecystitis Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Cause
        • 10.3.2.2.3. By Diagnostic Procedure
        • 10.3.2.2.4. By Treatment
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Acute Cholecystitis Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Cause
        • 10.3.3.2.3. By Diagnostic Procedure
        • 10.3.3.2.4. By Treatment
        • 10.3.3.2.5. By End User
    • 10.3.4. Chile Acute Cholecystitis Treatment Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Cause
        • 10.3.4.2.3. By Diagnostic Procedure
        • 10.3.4.2.4. By Treatment
        • 10.3.4.2.5. By End User

11. Middle East and Africa Acute Cholecystitis Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Cause
    • 11.2.3. By Diagnostic Procedure
    • 11.2.4. By Treatment
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Acute Cholecystitis Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Cause
        • 11.3.1.2.3. By Diagnostic Procedure
        • 11.3.1.2.4. By Treatment
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Acute Cholecystitis Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Cause
        • 11.3.2.2.3. By Diagnostic Procedure
        • 11.3.2.2.4. By Treatment
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Acute Cholecystitis Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Cause
        • 11.3.3.2.3. By Diagnostic Procedure
        • 11.3.3.2.4. By Treatment
        • 11.3.3.2.5. By End User
    • 11.3.4. Turkey Acute Cholecystitis Treatment Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type
        • 11.3.4.2.2. By Cause
        • 11.3.4.2.3. By Diagnostic Procedure
        • 11.3.4.2.4. By Treatment
        • 11.3.4.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
    • 14.2.1. Boston Scientific Corporation
    • 14.2.2. Fresenius Kabi AG
    • 14.2.3. Pfizer Inc
    • 14.2.4. Teva Pharmaceutical Industries Ltd.
    • 14.2.5. Glenmark Pharmaceuticals Limited
    • 14.2.6. Merck & Co., Inc.
    • 14.2.7. Becton, Dickinson and Company
    • 14.2.8. Simulab Corporation
    • 14.2.9. AbbVie, Inc.
    • 14.2.10. Fortimedix Surgical BV

15. Strategic Recommendations